ATE101519T1 - Verwendung von gestoden zur herstellung von arzneimitteln. - Google Patents
Verwendung von gestoden zur herstellung von arzneimitteln.Info
- Publication number
- ATE101519T1 ATE101519T1 AT90250128T AT90250128T ATE101519T1 AT E101519 T1 ATE101519 T1 AT E101519T1 AT 90250128 T AT90250128 T AT 90250128T AT 90250128 T AT90250128 T AT 90250128T AT E101519 T1 ATE101519 T1 AT E101519T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- gestoden
- pharmaceuticals
- manufacture
- estradien
- Prior art date
Links
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 102000009618 Transforming Growth Factors Human genes 0.000 abstract 1
- 108010009583 Transforming Growth Factors Proteins 0.000 abstract 1
- 229940046836 anti-estrogen Drugs 0.000 abstract 1
- 230000001833 anti-estrogenic effect Effects 0.000 abstract 1
- 201000008275 breast carcinoma Diseases 0.000 abstract 1
- 239000000328 estrogen antagonist Substances 0.000 abstract 1
- 229960005352 gestodene Drugs 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3916381A DE3916381A1 (de) | 1989-05-17 | 1989-05-17 | Verwendung von gestoden zur herstellung von arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE101519T1 true ATE101519T1 (de) | 1994-03-15 |
Family
ID=6381002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90250128T ATE101519T1 (de) | 1989-05-17 | 1990-05-17 | Verwendung von gestoden zur herstellung von arzneimitteln. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0399631B1 (de) |
| JP (1) | JPH0386826A (de) |
| CN (1) | CN1047298A (de) |
| AT (1) | ATE101519T1 (de) |
| AU (1) | AU640139B2 (de) |
| CA (1) | CA2016895A1 (de) |
| DD (1) | DD298883A5 (de) |
| DE (2) | DE3916381A1 (de) |
| DK (1) | DK0399631T3 (de) |
| ES (1) | ES2062312T3 (de) |
| HU (1) | HUT54501A (de) |
| IE (1) | IE65717B1 (de) |
| IL (1) | IL94417A (de) |
| PT (1) | PT94051B (de) |
| ZA (1) | ZA903803B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| FR2833837B1 (fr) * | 2001-12-21 | 2005-08-05 | Oreal | Composition pour la teinture d'oxydation des fibres keratiniques comprenant un amide d'acide gras de colza oxyethylene |
| JP4775563B2 (ja) * | 2006-03-31 | 2011-09-21 | Ｎｏｋ株式会社 | センターベアリングサポート |
| JP2009078123A (ja) | 2007-09-07 | 2009-04-16 | Morito Co Ltd | 取付部品と取付対象物との連結方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0310542B1 (de) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren |
-
1989
- 1989-05-17 DE DE3916381A patent/DE3916381A1/de not_active Withdrawn
-
1990
- 1990-05-16 IL IL9441790A patent/IL94417A/en not_active IP Right Cessation
- 1990-05-16 PT PT94051A patent/PT94051B/pt not_active IP Right Cessation
- 1990-05-16 CA CA002016895A patent/CA2016895A1/en not_active Abandoned
- 1990-05-16 HU HU903055A patent/HUT54501A/hu unknown
- 1990-05-17 CN CN90103702A patent/CN1047298A/zh active Pending
- 1990-05-17 AU AU55135/90A patent/AU640139B2/en not_active Ceased
- 1990-05-17 ZA ZA903803A patent/ZA903803B/xx unknown
- 1990-05-17 DE DE69006633T patent/DE69006633T2/de not_active Expired - Lifetime
- 1990-05-17 IE IE177590A patent/IE65717B1/en not_active IP Right Cessation
- 1990-05-17 AT AT90250128T patent/ATE101519T1/de not_active IP Right Cessation
- 1990-05-17 DD DD90340770A patent/DD298883A5/de not_active IP Right Cessation
- 1990-05-17 DK DK90250128.7T patent/DK0399631T3/da active
- 1990-05-17 EP EP90250128A patent/EP0399631B1/de not_active Expired - Lifetime
- 1990-05-17 JP JP2125615A patent/JPH0386826A/ja active Pending
- 1990-05-17 ES ES90250128T patent/ES2062312T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0399631T3 (da) | 1994-06-06 |
| PT94051A (pt) | 1991-01-08 |
| CA2016895A1 (en) | 1990-11-17 |
| HU903055D0 (en) | 1990-09-28 |
| HUT54501A (en) | 1991-03-28 |
| IL94417A0 (en) | 1991-03-10 |
| AU640139B2 (en) | 1993-08-19 |
| DD298883A5 (de) | 1992-03-19 |
| DE69006633D1 (de) | 1994-03-31 |
| CN1047298A (zh) | 1990-11-28 |
| IL94417A (en) | 1995-07-31 |
| AU5513590A (en) | 1990-11-29 |
| ES2062312T3 (es) | 1994-12-16 |
| DE69006633T2 (de) | 1994-08-25 |
| IE901775L (en) | 1990-11-17 |
| ZA903803B (en) | 1991-03-27 |
| EP0399631A1 (de) | 1990-11-28 |
| EP0399631B1 (de) | 1994-02-16 |
| IE65717B1 (en) | 1995-11-15 |
| JPH0386826A (ja) | 1991-04-11 |
| DE3916381A1 (de) | 1990-11-22 |
| PT94051B (pt) | 1996-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE79763T1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
| DE3779346D1 (de) | Zusammensetzung zur behandlung der haut. | |
| ATE79536T1 (de) | Tamoxifen zur topischen verwendung. | |
| DE68918217D1 (de) | Familie von modifizierten Antikörpern mit hoher Affinität zur Behandlung von Krebs. | |
| DE68915503D1 (de) | Zahnchirurgisches Gerät, geeignet für die Versorgung von gekoppelten Handstücken mit drei unterschiedlichen Fluida. | |
| DE69718469D1 (de) | Verbindungen mit wachtumshormon freisetzenden eigenschaften | |
| ATE22655T1 (de) | Infusionsloesungen zur herztherapie. | |
| ATE101519T1 (de) | Verwendung von gestoden zur herstellung von arzneimitteln. | |
| EP0266993A3 (en) | Method and therapeutic compositions for the treatment of bleeding disorders | |
| DE69004794D1 (de) | Verwendung eines Polypeptids mit Interleukin 2-Aktivität zur Herstellung einer zur Behandlung von einfachen Pleurageschwüren bestimmten pharmazeutischen Zusammensetzung. | |
| IT8419730A0 (it) | Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3. | |
| EP0424156A3 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
| ATE500269T1 (de) | Verbindungen mit wachstumshormon-freisetzenden eigenschaften | |
| IT8420213A0 (it) | Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi. | |
| DK99987A (da) | Oestrogenpraeparater | |
| DE3770361D1 (de) | Azolderivate, geeignet zur bekaempfung von pflanzen-krankheiten. | |
| ZA849576B (en) | 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases | |
| DE69023459D1 (de) | Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten. | |
| DE3380923D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen. | |
| DE3784768D1 (de) | Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen. | |
| ATE58397T1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
| DE3575732D1 (de) | Verwendung von gonadoliberin und gonadoliberinagonisten zur herstellung einer pharmazeutischen zubereitung. | |
| DE69113773D1 (de) | Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma. | |
| IT1237087B (it) | N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono. | |
| IT8619249A0 (it) | Kit per la determinazione dell'attivita' proliferativa nei tumori umani. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |